Lessons from a population‐based bladder cancer registry: exploring why survival is not improving
BJU International · 2024
DOI: 10.1111/bju.16286 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJU International, 2024. Verfasst von Jake A Tempo und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Registries. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To explore the causes of the decrease in bladder cancer survival that has occurred over the past four decades.
Methods
We extracted data from the South Australian Cancer Registry. Data from the period 1 January 1977 to 31 December 2020 were extracted to explore changes in incidence and survival among a total of 8356 patients diagnosed with ≥pT1 disease. Invasive bladder cancer was defined as ≥pT1 in this study.
Results
Invasive bladder cancer age‐standardized incidence decreased from 7.20 cases per 100 000 people in 1977 to 5.85 cases per 100 000 in 2020. The mean age at diagnosis increased from 68 years to 76 years. The crude incidence for patients aged 80 years and over increased by 3.3% per year (95% confidence interval [CI] 2.1 to 4.6). Overall survival decreased over the study period (hazard ratio [HR] 1.22 [95% CI 1.09 to 1.35]), however, survival increased after adjusting for age at diagnosis (HR 0.80 [95% CI 0.76 to 0.94]). Despite a decrease in non‐bladder cancer‐specific deaths in older people, there was no change in the bladder cancer‐specific death rate in older people (HR 0.94 [95% CI 0.70 to 1.26]). Male sex was associated with higher survival (HR 0.87 [95% CI 0.83 to 0.92]), whereas socioeconomic advantage was not.
Conclusions
Invasive bladder cancer survival has decreased over the past 40 years, with the age structure of the population being a significant contributing factor. Patient summary We looked at why bladder cancer survival is decreasing using a large cancer registry with information from 1977 to 2020. We found that people are now more likely to be diagnosed at an older age. Older people often live for a shorter time with bladder cancer compared to younger people. Bladder cancer survival has decreased because there are more older people with the disease than previously.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
- Urology Unit, Austin Health, Melbourne, VIC, Australia.
- Urology Unit, Sunshine Coast University Hospital, Sunshine Coast, QLD, Australia.
- Prevention and Population Health, Wellbeing SA, Adelaide, SA, Australia.
- Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia.
- Urology Unit, Flinders Medical Centre, Bedford Park, SA, Australia.
ORCID-Profile: Jake A Tempo, Michael O'Callaghan
Zitieren
APA
Tempo, J. A., Sii, S., Ischia, J., Bolton, D. M., D'Onise, K., Meng, R., Watson, D. I., & O'Callaghan, M. (2024). Lessons from a population‐based bladder cancer registry: exploring why survival is not improving. BJU International. https://doi.org/10.1111/bju.16286
Vancouver
Tempo JA, Sii S, Ischia J, Bolton DM, D'Onise K, Meng R, et al. Lessons from a population‐based bladder cancer registry: exploring why survival is not improving. BJU International. 2024. doi:10.1111/bju.16286
BibTeX
@article{Tempo2024,
author = {Tempo, Jake A and Sii, Samuel and Ischia, Joseph and Bolton, Damien M and D'Onise, Katina and Meng, Rosie and Watson, David I and O'Callaghan, Michael},
title = {Lessons from a population‐based bladder cancer registry: exploring why survival is not improving},
journal = {BJU International},
year = {2024},
doi = {10.1111/bju.16286}
}
EUVIMED